Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pasireotide is a stable cyclohexapeptide somatostatin mimic.
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,740 | 待询 | ||
5 mg | ¥ 5,740 | 待询 | ||
10 mg | ¥ 9,150 | 待询 | ||
50 mg | 待询 | 待询 | ||
100 mg | 待询 | 待询 |
Pasireotide ditrifluoroacetate 的其他形式现货产品:
产品描述 | Pasireotide is a stable cyclohexapeptide somatostatin mimic. |
靶点活性 | SST2:9 (pki), SST5:9.9(pki), SST4:<7.0 (pki), SST1:pki:8.2 , SST3:9.1(pki) |
体外活性 | SOM230, a novel, stable cyclohexapeptide somatostatin mimic that exhibits unique high-affinity binding to human somatostatin receptors (subtypes sst1-sst5).?SOM230 has potent, long-lasting inhibitory effects on growth hormone and insulin-like growth factor-1 release[1] |
体内活性 | Untreated SSTR2(-/-) mice with AIA displayed joint swelling and mechanical hyperalgesia similar to that seen in SSTR2(+/+) mice.?In wild-type mice, both octreotide and pasireotide significantly attenuated knee joint swelling and histopathologic manifestations of arthritis to an extent comparable to that of dexamethasone.?In SSTR2(-/-) mice, the antiinflammatory effects of both octreotide and pasireotide were completely abrogated.?Prolonged administration of pasireotide also inhibited joint swelling and protected against joint destruction during AIA flare reactions.?In addition, both octreotide and pasireotide reduced inflammatory hyperalgesia.?The antinociceptive actions of octreotide were abolished in SSTR2(-/-) mice, but those of pasireotide were retained.?In dorsal root ganglia of naive wild-type mice, only SSTR1 and SSTR2A, but not SSTR3 or SSTR5, were detected in a subset of small- and medium-diameter neurons[1]. |
别名 | SOM230 ditrifluoroacetate, Pasireotide ditrifluoroacetate (396091-73-9 free base), Pasireotide TFA salt |
分子量 | 1275.25 |
分子式 | C62H68F6N10O13 |
CAS No. | T13811 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Pasireotide ditrifluoroacetate T13811 Others SOM 230 SOM230 Ditrifluoroacetate SOM230 ditrifluoroacetate 396091-73-9 Pasireotide ditrifluoroacetate (396091-73-9 free base) SOM 230 Ditrifluoroacetate 396091-73-9 free base Pasireotide Ditrifluoroacetate Pasireotide TFA salt Pasireotide TFA Pasireotide SOM-230 SOM-230 Ditrifluoroacetate SOM230 Inhibitor inhibitor inhibit